Literature DB >> 2508479

Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix.

J Grøndahl-Hansen1, L T Kirkeby, E Ralfkiaer, P Kristensen, L R Lund, K Danø.   

Abstract

Urokinase and tissue-type plasminogen activators (u-PA and t-PA) were identified immunohistochemically in normal and inflamed human appendices by means of polyclonal and monoclonal antibodies. In addition, extracts of the tissues were analyzed for u-PA and t-PA by ELISA. Twelve appendices (five normal and seven with acute inflammation) were analyzed. In the normal appendices, there was a strong staining of the endothelial cells for t-PA, whereas there was negative staining for u-PA. In contrast, the endothelial cells in the inflamed appendices showed u-PA immunoreactivity, and negative or very weak reactions for t-PA. In the inflamed appendix, there was also a labeling of u-PA in fibroblast-like cells and in interstitial areas. The specificity of the staining was supported by a variety of staining controls and also by analysis of tissue extracts with ELISA, showing that on the average the inflamed appendices contained more than twice as much mu-PA per mg of protein as the normal appendices and less than one third of the amount of t-PA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508479      PMCID: PMC1880031     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Tissue-type plasminogen activator in rat adrenal medulla.

Authors:  P Kristensen; D M Hougaard; L S Nielsen; K Danø
Journal:  Histochemistry       Date:  1986

2.  Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.

Authors:  J Grøndahl-Hansen; E Ralfkiaer; L S Nielsen; P Kristensen; G Frentz; K Danø
Journal:  J Invest Dermatol       Date:  1987-01       Impact factor: 8.551

Review 3.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

4.  Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels.

Authors:  V W van Hinsbergh; D Binnema; M A Scheffer; E D Sprengers; T Kooistra; D C Rijken
Journal:  Arteriosclerosis       Date:  1987 Jul-Aug

5.  Plasminogen activator in psoriatic scales is of the tissue-type PA as identified by monoclonal antibodies.

Authors:  J Grøndahl-Hansen; L S Nielsen; P Kristensen; V Grøndahl-Hansen; P A Andreasen; K Danø
Journal:  Br J Dermatol       Date:  1985-09       Impact factor: 9.302

6.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.

Authors:  J D Vassalli; D Baccino; D Belin
Journal:  J Cell Biol       Date:  1985-01       Impact factor: 10.539

7.  Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse.

Authors:  L I Larsson; L Skriver; L S Nielsen; J Grøndahl-Hansen; P Kristensen; K Danø
Journal:  J Cell Biol       Date:  1984-03       Impact factor: 10.539

Review 8.  Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.

Authors:  F Blasi; J D Vassalli; K Danø
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

9.  Immunocytochemical demonstration of tissue-type plasminogen activator in endocrine cells of the rat pituitary gland.

Authors:  P Kristensen; L S Nielsen; J Grøndahl-Hansen; P B Andresen; L I Larsson; K Danø
Journal:  J Cell Biol       Date:  1985-07       Impact factor: 10.539

10.  Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.

Authors:  E G Levin; D J Loskutoff
Journal:  J Cell Biol       Date:  1982-09       Impact factor: 10.539

View more
  6 in total

1.  Immunohistological detection of Saruplase (recombinant single-chain urokinase-type plasminogen activator) in normal rat tissue.

Authors:  T Wöhrmann; T Matthiesen; H Beier; L Flohé
Journal:  Histochemistry       Date:  1991

2.  Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans.

Authors:  J Grøndahl-Hansen; E Ralfkiaer; L T Kirkeby; P Kristensen; L R Lund; K Danø
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

3.  Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.

Authors:  C Pyke; P Kristensen; E Ralfkiaer; J Grøndahl-Hansen; J Eriksen; F Blasi; K Danø
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

4.  Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis.

Authors:  M Ge; G Tang; T J Ryan; A B Malik
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

5.  Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.

Authors:  M A Wodziński; K D Bardhan; J T Reilly; P Cooper; F E Preston
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

6.  Upregulation of urokinase receptor expression on migrating endothelial cells.

Authors:  M S Pepper; A P Sappino; R Stöcklin; R Montesano; L Orci; J D Vassalli
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.